A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...
Morning Overview on MSN
A targeted pill and a custom mRNA vaccine are both beating back pancreatic cancer in early trials — cracking open one of medicine’s hardest tumors
Pancreatic ductal adenocarcinoma has a five-year survival rate of roughly 13 percent, according to the American Cancer ...
Researchers have uncovered an unexpected weakness in pancreatic cancer involving damaged mitochondria and a powerful ...
Scientists found that leaking mitochondrial RNA helps pancreatic tumors survive, revealing a promising new treatment target.
Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors. Now, researchers at University of California San Diego School of Medicine ...
Severe acute pancreatitis (SAP) remains one of the most formidable challenges in gastrointestinal emergency medicine.
No evidence supports a significant link between gastroesophageal reflux disease (GERD) and pancreatitis. However, they share some risk factors, such as excessive alcohol consumption and obesity.
NSCLC showed the largest reduction in metastatic progression with GLP-1RAs versus gliptins (HR 0.50), with significant ...
IgG4-related sclerosing disease is an immune-mediated disease that affects multiple organs at the same time in some people. This can often include an inflamed pancreas, organ swelling, disease in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results